ISMAILIA — Egypt plans to channel investments of up to EGP 12 billion (approximately $240 million) into its Vaccine and Biotechnology City by 2030 as Cairo seeks to strengthen pharmaceutical self-sufficiency, reduce reliance on imported vaccines and position itself as a regional manufacturing hub serving African and Middle Eastern markets. The project forms part of a broader strategy […] The post Egypt Bets EGP 12bn on Vaccine Hub to Cut Imports…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.